These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 15975013)

  • 1. Recent developments in recombinant AAV-mediated gene therapy for lung diseases.
    Flotte TR
    Curr Gene Ther; 2005 Jun; 5(3):361-6. PubMed ID: 15975013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AAV hybrid serotypes: improved vectors for gene delivery.
    Choi VW; McCarty DM; Samulski RJ
    Curr Gene Ther; 2005 Jun; 5(3):299-310. PubMed ID: 15975007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue and cell-type-specific transduction using rAAV vectors in lung diseases.
    Kochergin-Nikitsky K; Belova L; Lavrov A; Smirnikhina S
    J Mol Med (Berl); 2021 Aug; 99(8):1057-1071. PubMed ID: 34021360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of clinical-grade recombinant adeno-associated virus vectors.
    Snyder RO; Flotte TR
    Curr Opin Biotechnol; 2002 Oct; 13(5):418-23. PubMed ID: 12459331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of AAV serotypes for lung gene therapy in human embryonic stem cell-derived lung organoids.
    Meyer-Berg H; Zhou Yang L; Pilar de Lucas M; Zambrano A; Hyde SC; Gill DR
    Stem Cell Res Ther; 2020 Oct; 11(1):448. PubMed ID: 33097094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vector serotype screening for use in ovine perinatal lung gene therapy.
    McClain LE; Davey MG; Zoltick PW; Limberis MP; Flake AW; Peranteau WH
    J Pediatr Surg; 2016 Jun; 51(6):879-84. PubMed ID: 27032612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-complementary and tyrosine-mutant rAAV vectors enhance transduction in cystic fibrosis bronchial epithelial cells.
    Lopes-Pacheco M; Kitoko JZ; Morales MM; Petrs-Silva H; Rocco PRM
    Exp Cell Res; 2018 Nov; 372(2):99-107. PubMed ID: 30244179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of AAV Capsid-Specific T-Cell Responses on Design and Outcome of Clinical Gene Transfer Trials with Recombinant Adeno-Associated Viral Vectors: An Evolving Controversy.
    Ertl HCJ; High KA
    Hum Gene Ther; 2017 Apr; 28(4):328-337. PubMed ID: 28042943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-dressing the virion: the transcapsidation of adeno-associated virus serotypes functionally defines subgroups.
    Rabinowitz JE; Bowles DE; Faust SM; Ledford JG; Cunningham SE; Samulski RJ
    J Virol; 2004 May; 78(9):4421-32. PubMed ID: 15078923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Integration of AAV vectors and insertional mutagenesis].
    Rossi A; Salvetti A
    Med Sci (Paris); 2016 Feb; 32(2):167-74. PubMed ID: 26936174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the ability of adeno-associated viral vectors pseudotyped with serotype 2, 5, and 8 capsid proteins to mediate efficient transduction of the liver in murine and nonhuman primate models.
    Davidoff AM; Gray JT; Ng CY; Zhang Y; Zhou J; Spence Y; Bakar Y; Nathwani AC
    Mol Ther; 2005 Jun; 11(6):875-88. PubMed ID: 15922958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and biological efficacy of an adeno-associated virus vector-cystic fibrosis transmembrane regulator (AAV-CFTR) in the cystic fibrosis maxillary sinus.
    Wagner JA; Messner AH; Moran ML; Daifuku R; Kouyama K; Desch JK; Manley S; Norbash AM; Conrad CK; Friborg S; Reynolds T; Guggino WB; Moss RB; Carter BJ; Wine JJ; Flotte TR; Gardner P
    Laryngoscope; 1999 Feb; 109(2 Pt 1):266-74. PubMed ID: 10890777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AAV's anatomy: roadmap for optimizing vectors for translational success.
    Mitchell AM; Nicolson SC; Warischalk JK; Samulski RJ
    Curr Gene Ther; 2010 Oct; 10(5):319-340. PubMed ID: 20712583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced gene transfer efficiency in the murine striatum and an orthotopic glioblastoma tumor model, using AAV-7- and AAV-8-pseudotyped vectors.
    Harding TC; Dickinson PJ; Roberts BN; Yendluri S; Gonzalez-Edick M; Lecouteur RA; Jooss KU
    Hum Gene Ther; 2006 Aug; 17(8):807-20. PubMed ID: 16942441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene therapy in cystic fibrosis.
    Flotte TR; Laube BL
    Chest; 2001 Sep; 120(3 Suppl):124S-131S. PubMed ID: 11555567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New developments in the generation of Ad-free, high-titer rAAV gene therapy vectors.
    Ferrari FK; Xiao X; McCarty D; Samulski RJ
    Nat Med; 1997 Nov; 3(11):1295-7. PubMed ID: 9359708
    [No Abstract]   [Full Text] [Related]  

  • 17. Prospects for virus-based gene therapy for cystic fibrosis.
    Flotte TR
    J Bioenerg Biomembr; 1993 Feb; 25(1):37-42. PubMed ID: 8382676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delivering Transgenic DNA Exceeding the Carrying Capacity of AAV Vectors.
    Hirsch ML; Wolf SJ; Samulski RJ
    Methods Mol Biol; 2016; 1382():21-39. PubMed ID: 26611576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Origins of truncated supplementary capsid proteins in rAAV8 vectors produced with the baculovirus system.
    Galibert L; Savy A; Dickx Y; Bonnin D; Bertin B; Mushimiyimana I; van Oers MM; Merten OW
    PLoS One; 2018; 13(11):e0207414. PubMed ID: 30440025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New recombinant serotypes of AAV vectors.
    Gao G; Vandenberghe LH; Wilson JM
    Curr Gene Ther; 2005 Jun; 5(3):285-97. PubMed ID: 15975006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.